Jean-Luc Berland Selected Research

tert-butylbicyclophosphorothionate

10/2019

First insights into the genetic characteristics and drug resistance of Mycobacterium tuberculosis population collected during the first national tuberculosis prevalence survey of Lao PDR (2010-2011).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jean-Luc Berland Research Topics

Disease

3	Infections 03/2007 - 09/2005
1	Leprosy (Hansen's Disease) 01/2020
1	Pulmonary Tuberculosis 01/2020
1	Tuberculosis (Tuberculoses) 10/2019
1	Severe Acute Respiratory Syndrome 03/2006
1	Liver Diseases (Liver Disease) 10/2004
1	Chronic Hepatitis C 10/2004
1	Virus Diseases (Viral Diseases) 10/2004
1	Vaccinia 09/2004

Drug/Important Bio-Agent (IBA)

3	AntigensIBA 03/2007 - 09/2005
3	Proteins (Proteins, Gene)FDA Link 03/2006 - 10/2004
2	VaccinesIBA 03/2007 - 09/2005
1	GoldIBA 01/2020
1	InterferonsIBA 01/2020
1	N 30IBA 01/2020
1	heparin-binding hemagglutininIBA 01/2020
1	tert-butylbicyclophosphorothionateIBA 10/2019
1	Isoniazid (Ftivazide)FDA LinkGeneric 10/2019
1	Rifampin (Rifampicin)FDA LinkGeneric 10/2019
1	Recombinant ProteinsIBA 03/2006
1	DNA (Deoxyribonucleic Acid)IBA 09/2005
1	RNA (Ribonucleic Acid)IBA 10/2004
1	AntibodiesIBA 10/2004
1	EnzymesIBA 10/2004
1	ImmunosorbentsIBA 10/2004
1	Glycoproteins (Glycoprotein)IBA 09/2004